Companies Raise More Than Rs 84,300 Crore Via IPOs In FY18
Indian companies garnered Rs 84,357 crore through initial share sales in 2017-18, registering a nearly three-fold jump compared to the preceding fiscal, says a report.
According to the study by PRIME Database, the amount raised by firms through the initial public offer route stood at Rs 29,050 crore during 2016-17.
"2017-18 was the best year ever for the IPO market by far, the previous high being in 2007-08 when Rs 41,323 crore was raised, less than half of the amount raised in 2017-18," said Pranav Haldea, Managing Director, PRIME Database.
While there were 45 main-board IPOs during 2017-18 collectively raising Rs 82,109 crore, the preceding fiscal saw 25 of them together garnering Rs 28,225 crore.
Also Read: LIC Funded Nearly 50% Of Government IPOs In FY18
As per the report, the largest initial share sale was from state-owned General Insurance Corporation of India for Rs 11,257 crore and the average deal size stood at Rs 1,825 crore.
Among the main-board IPOs, the issue of Salasar Techno Engineering received the best response with a subscription of 270 times, followed by Astron Paper & Board Mill at 241 times and Apollo Micro Systems at 176 times.
During 2017-18, there were 155 SME IPOs raising Rs 2,247 crore compared to 80 in the previous fiscal garnering Rs 825 crore.
The largest SME IPO in 2017-18 was from East India Securities (worth Rs 88 crore), the report said.
"2018-19 is likely to see more volatility in the secondary market which shall affect fund raising plans of companies as well.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.